PT2977, a Novel HIF-2a Antagonist, Affords Potent Anti-Tumor Activity and Remodels the...
Read More
Productivity, Satisfaction, and HealthRelated Quality of Life in Advanced Renal Cell Carcinoma...
Read More
Predictive genomic markers of response to VEGF targeted therapy (TT) in metastatic renal cell...
Read More
Plasma glycosaminoglycan scores in early stage renal cell carcinoma Abstract No diagnostic blood...
Read More
Physician Treatment Selection in the Prospective Metastatic Renal Cell Cancer (MaRCC) Registry...
Read More